# Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss

> **NCT03305263** · PHASE3 · UNKNOWN · sponsor: **Rigshospitalet, Denmark** · enrollment: 186 (estimated)

## Conditions studied

- Recurrent Pregnancy Loss

## Interventions

- **DRUG:** Hydroxychloroquine
- **DRUG:** Hydroxychloroquine placebo

## Key facts

- **NCT ID:** NCT03305263
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-25
- **Primary completion:** 2022-01
- **Final completion:** 2023-01
- **Target enrollment:** 186 (ESTIMATED)
- **Last updated:** 2020-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03305263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03305263, "Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03305263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*